Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immune cell trafficking from the brain maintains CNS immune tolerance.
Keeping cool: use of air conditioning by australians with multiple sclerosis.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
The spectrum of MOG autoantibody-associated demyelinating diseases.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
Cyclophosphamide for multiple sclerosis.
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials.
Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
JC viremia in natalizumab-treated patients with multiple sclerosis.

Pages